What Natulab does

Natulab is a Brazilian pharmaceutical company founded in 2000 and headquartered in São Paulo, specializing in the development, manufacture, and distribution of phytotherapeutic (herbal) medicines certified by ANVISA (Brazil's national health surveillance agency). The company operates an ANVISA-certified manufacturing plant in Santo Antônio de Jesus, Bahia, plus a commercial office in São Paulo's Vila Olímpia district. Natulab markets a diversified portfolio across multiple therapeutic categories, including pain and fever (Arpynflan, based on Harpagophytum procumbens), digestive health (Alcachofra Natulab, Cardomarin, Epaphyto, Espinheira Santa, Aftliv), nervous system conditions (Seakalm, Valessone), women's health (Pausefemme), and circulatory conditions (Varivax), with each product built around standardized plant extracts formulated at controlled dosages with regulatory safety and efficacy certification.

Natulab distributes its products primarily through Brazil's national pharmacy network as both OTC and prescription medications, and supplies medications to Brazil's public health system (SUS), giving it dual retail-consumer and institutional reach. The company claims to lead Brazil's phytotherapeutic segment with one of the most complete portfolios in the category, with 10+ core brands spanning major therapeutic categories. Its go-to-market strategy blends content marketing (health-education articles on its website categorized by therapeutic area), organic social media presence on LinkedIn, Facebook, and Instagram, and earned media through external press offices (CDI Comunicação and Pipa Comunicação). The company has invested in sustainability initiatives including an ESG committee, diversity and inclusion programs, and reverse-logistics partnerships with pharmacies for medication disposal.

Revenue figures, ownership, and financial performance are not publicly disclosed. Natulab employs 501-1000 people and operates as a privately held Brazilian corporation with no public ticker, no disclosed funding rounds, and no parent company or institutional investor relationships identified in available data. Pricing is not transparently published; the company's stated value proposition emphasizes accessibility for Brazilian families and natural-formula benefits compared to synthetic alternatives.

Name

Natulab

Legal name

Natulab

Website

https://natulab.com.br

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Natulab is a Brazilian pharmaceutical manufacturer founded in 2000 and headquartered in São Paulo, specializing in ANVISA-certified phytotherapeutic (herbal) medicines distributed through Brazilian pharmacies and supplied to the public health system (SUS) across multiple therapeutic categories.

Ownership category

akta.pro rank

Product category

Herbal Pharmaceuticals

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)

akta.pro primary industry

Herbal & Botanical Supplements (CRADAGAD)

akta.pro secondary industry

Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts) (AFAJAKAD)

Keywords

• Herbal pharmaceuticals
• Phytotherapeutic medicines
• Plant-based medications
• OTC supplements
• ANVISA-certified remedies

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Distribution channels1 record

Marketing channels5 records

Core offering

Natulab manufactures and sells ANVISA-certified herbal/plant-based medicines (fitoterápicos) in Brazil, producing medications from standardized plant extracts such as Passiflora incarnata, Valeriana officinalis, Harpagophytum procumbens, Cynara scolymus, Silybum marianum, Peumus boldus, Maytenus ilicifolia, Aesculus hippocastanum, and Glycine max. The portfolio spans pain relief, digestive health, women's health, nervous system treatments, respiratory care, and vitamins/supplements, distributed through pharmacies nationwide and supplied to the public health system (SUS).

Product overview

Natulab is a Brazilian pharmaceutical company that leads the production and sale of ANVISA-certified herbal/plant-based medicines in Brazil, with one of the most complete portfolios in the segment. The company develops medications manufactured from plant extracts, combining tradition and innovation to provide safe, effective, and accessible health products. The portfolio includes treatments for: pain and fever (Arpynflan), digestive problems (Aftliv, Alcachofra Natulab, Cardomarin, Epaphyto, Espinheira Santa Natulab), women's health and circulatory system (Pausefemme, Varivax), nervous system conditions (Seakalm, Valessone), respiratory health, vitamins and supplements, and skin care.

Differentiator

Problem solved

Functional benefit

Products and services

• Seakalm (Passiflora incarnata)

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• EMS Farmacêutica: Largest Brazilian pharmaceutical manufacturer by volume with broad prescription, generic, and OTC portfolio distributed nationally through the same pharmacy networks that carry Natulab.
• Eurofarma Laboratórios: Major Brazilian pharmaceutical company with diversified prescription, OTC, and consumer health operations including phytotherapeutic categories that overlap with Natulab's portfolio.
• Biolab Farmacêutica: Brazilian specialty pharmaceutical manufacturer with prescription and OTC products across multiple therapeutic areas; competes with Natulab through overlapping indications and pharmacy distribution.
• Aché Laboratórios: One of Brazil's largest pharmaceutical companies offering prescription, OTC, and consumer health products including herbal lines; overlaps with Natulab through broad pharmacy-channel distribution and some phytotherapeutic presence.
• Hyper Pharma (Hypera Pharma): Brazil's largest consumer health and OTC pharmaceutical company (owner of brands such as Aprix and Neo Química) with extensive pharmacy-channel presence overlapping Natulab's distribution.
• Sanofi Consumer Healthcare Brasil: Global pharmaceutical and consumer health company with established Brazilian OTC and natural health portfolio, competing with Natulab in pharmacy retail across multiple indications.
• Takeda Brasil (Consumer Health): Global pharmaceutical company with Brazilian consumer health and OTC presence, competing with Natulab in digestive, nervous system, and women's health categories through pharmacy distribution.
• GSK Consumer Healthcare Brasil: Global consumer health company with significant Brazilian operations in OTC and natural health categories, competing with Natulab across digestive, respiratory, and wellness indications in Brazilian pharmacies.

Direct peers

• Herbarium Laboratório Botânico: Brazilian manufacturer of phytotherapeutic and herbal medicines, the most direct head-to-head competitor to Natulab in the same ANVISA-certified fitoterápicos segment with overlapping therapeutic categories.
• Laboratório Catarinense: Brazilian pharmaceutical laboratory with significant herbal and phytotherapeutic product lines, directly competing with Natulab in plant-based medicines sold through Brazilian pharmacies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Natulab